Yunlong Lu

机构：Nanjing University of Chinese Medicine, Indiana University School of Medicine · ORCID：0000-0001-6170-6013

发表论文 33 篇 · 总被引 1415 次 · h-index 20

代表论文

Recent development of gold( i ) and gold( iii ) complexes as therapeutic agents for cancer diseases (2022 · Chemical Society Reviews · 被引 246)
Mecheliolide elicits ROS-mediated ERS driven immunogenic cell death in hepatocellular carcinoma (2022 · Redox Biology · 被引 150)
Pt(II)-NHC Complex Induces ROS-ERS-Related DAMP Balance to Harness Immunogenic Cell Death in Hepatocellular Carcinoma (2022 · Journal of Medicinal Chemistry · 被引 80)
Repurposing of the gold drug auranofin and a review of its derivatives as antibacterial therapeutics (2022 · Drug Discovery Today · 被引 75)
Induction of immunogenic cell death by novel platinum-based anticancer agents (2022 · Pharmacological Research · 被引 72)
Tumor-Targeting NHC–Au(I) Complex Induces Immunogenic Cell Death in Hepatocellular Carcinoma (2023 · Journal of Medicinal Chemistry · 被引 65)